CEREBYX

This brand name is authorized in Canada, United States

Active ingredients

The drug CEREBYX contains one active pharmaceutical ingredient (API):

1 Fosphenytoin
UNII 7VLR55452Z - FOSPHENYTOIN SODIUM

Fosphenytoin is a water-soluble phosphate ester prodrug of phenytoin, a hydantoin derivative with anticonvulsant activity. Fosphenytoin is hydrolyzed to phenytoin by phosphatases. Phenytoin exerts its effect mainly by promoting sodium efflux and stabilizes neuronal membranes in the motor cortex. This leads to a suppression of excessive neuronal firing and limits the spread of seizure activity.

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
CEREBYX Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N03AB05 Fosphenytoin N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AB Hydantoin derivatives
Discover more medicines within N03AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02230988
Country: US FDA, National Drug Code Identifier(s): 0069-5471, 0069-5474, 0069-6001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.